Displaying 1 - 9 of 9
Liver Tumours
5

Bayer: Addressing a Changing Treatment Dynamic in HCC:  Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021

View
Liver Tumours
5

Bayer: Addressing a Changing Treatment Dynamic in HCC:  Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021

View
Liver Tumours
5

Bayer: Addressing a Changing Treatment Dynamic in HCC:  Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021

View
Liver Tumours
5

Bayer: Addressing a Changing Treatment Dynamic in HCC:  Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021

View
Liver Tumours
5

Bayer: Addressing a Changing Treatment Dynamic in HCC:  Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021

View
General Hepatology
4

Gore & Associates: New clinical evidence demonstrates improved survival when selecting smaller TIPS and earlier TIPS - ILC 2021

View
General Hepatology
4

Gore & Associates: New clinical evidence demonstrates improved survival when selecting smaller TIPS and earlier TIPS - ILC 2021

View
General Hepatology
4

Gore & Associates: New clinical evidence demonstrates improved survival when selecting smaller TIPS and earlier TIPS - ILC 2021

View
General Hepatology
4

Gore & Associates: New clinical evidence demonstrates improved survival when selecting smaller TIPS and earlier TIPS - ILC 2021

View
Displaying 1 - 9 of 9